How much is Stylus Medicine worth in 2026?

Stylus Medicine has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Stylus Medicine raised?

Stylus Medicine has raised N/A in total funding across 1 funding rounds.

Stylus Medicine

Drug Discovery

Stylus Medicine valuation and funding history | Last updated: May 13, 2025 | 1 funding rounds

Current Valuation

N/A

As of May 13, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$85.0M

Last Funding

May 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 13, 2025	Early Stage VC (Series A)	$85.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Stylus Medicine is currently valued at N/A as of May 13, 2025.

Track Stylus Medicine Valuation Updates

Get notified when Stylus Medicine raises new funding or valuation changes

Explore More Data

Detailed analysis for Stylus Medicine

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Stylus Medicine's valuation history, funding rounds, and growth metrics.

No credit card required

What is Stylus Medicine Worth in 2026?

Stylus Medicine is a leading private company in the Drug Discovery sector. Track Stylus Medicine's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Stylus Medicine Valuation is Determined

Private company valuations like Stylus Medicine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.